Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SCMI reinstated on December 2010, this shell is owned by Dan Savino which has experience on Mergers and Acquisitions as of its LinkedIn profile:
http://www.linkedin.com/profile/view?id=11436363&authType=NAME_SEARCH&authToken=jGJj&locale=en_US&srchid=b675fe19-4062-42e5-b9a8-358eefe8ce85-0&srchindex=1&srchtotal=1&goback=.fps_PBCK_*1_Danny_Savino_*1_*1_*1_*1_*2_*1_Y_*1_*1_*1_false_1_R_true_*1_ca%3A0_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2&pvs=ps&trk=pp_profile_name_link
It's held super tight so far.
Sure. I took a look at AEGP, and it does not look like they are keeping up with filings. This is not the end of the rope, necessarily, but I prefer to see regular filings (see below).
Copied from the Dormant Shell's board:
http://investorshub.advfn.com/boards/board.aspx?board_id=9916
How to value a Shell Stock
MAJOR CONSIDERATIONS
VERIFIED SHELL STOCK LOOKING FOR AN ACQUISITION: it should be actively looking for a reverse merger. Verification can come from SEC reports, news releases, or verbally from company management.
EXPERIENCED MANAGEMENT: management must understand the mechanics of a reverse merger and know a good business opportunity. If management is not experienced, it is imperative they are working with an experienced consultant.
SEC REPORTING: it must report regularly to the SEC. This is known as a "reporting company." We want to be able to verify information about the company from public/legal filings . . . not by word of mouth or rumor. Believe it or not, there are public companies that are non-reporting.
CLEAN: it has little or no debt, no pending law suites, and little or no outstanding convertible securities (preferred stock or warrants). We don't want anything that can complicate the reverse merger.
SMALL NUMBER OF OUTSTANDING SHARES: the smaller the number of outstanding shares, the better. A smaller number of outstanding shares lessens the chance of a Reverse Stock Split. A Reverse Stock Split can lessen the chance of price appreciation.
LOW MARKET VALUE: basically, this is the buy low sell high rule. A Shell Stock with a low Market Value will have a greater chance of price appreciation than one with a high Market Value. (Market Value = price X shares outstanding). NOTE: the Profile List by Market Value sorts the Shell Companies from low to high Market Value.
CASH ON HAND: some Shell Companies have cash remaining from their previous business endeavors. Having cash to fund the new company's business plan will attract high quality candidates.
MINOR CONSIDERATIONS
TAX LOSS CARRY FORWARD: the new company can offset future net income with the Shell Stock's Tax Loss Carry Forward.
EXCHANGE LISTED: it is better for the Shell Stock to be listed on a stock exchange (NYSE, AMSE, NASDAQ, OTCBB). But, there are some quality Shell Companies that are trading on the Pink Sheets.
INDICATORS
INCREASED VOLUME/PRICE: increased volume and price with no news may be an indicator of a potential reverse merger. Information on a reverse merger sometimes leaks out and insiders/family/friends start buying before the reverse merger is announced.
CORPORATE ACTIVITY: cleaning up debts, law suits, and issuing reverse splits can indicate management is getting the shell company ready for a reverse merger.
Post your dormant shell plays here.
-======================-
AEGP's filings --
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=882800
On their 15/A --
-[16]- Rules 12g-4 and 12h-3 currently allow for
termination of registration of a class of
securities under Section 12(g) and suspension of
the duty to file reports under Section 15(d) when
the class of securities is held of record by less
than 300 persons, or by less than 500 persons
where the total assets of the issuer have not
exceeded $5 million on the last day of each of the
issuer's three most recent fiscal years. Also,
the Section 15(d) reporting obligation cannot be
suspended under Rule 12h-3 for a fiscal year in
which a Securities Act registration statement
relating to the class of securities becomes
effective. The revisions amend Rules 12g-4 and
12h-3 to change the asset test from $5 million to
$10 million.
Gregory_,
since you mention Kip, do you have any insight on AEGP? Just curious. I grabbed a few of those a while back because it looked like a shell play to me when they cleaned it up.
But I am not really a huge shell guy. It just looked good to me at the time.
I know it is one of Kips.
Thanks for any insight you might have on the shell or Kip.
Looks like Kip payed 0.06 / share. So, anything under that might be a bargain...
Transaction Type / Date Current Average
6 Month Return Shares /
Market Value Price Range Total Holdings
Eardley, Kip
Purchase
4/1/2011
-- 200.0K
$11.8K $0.06 - $0.06 15,319,500
Stock Ownership
R/S is typical in shell plays... at least from what I've seen. Comes with the territory... 1/10 is not that bad, actually. Seems like it is usually something like 1/100 or 1/250. FWIW
PNHV finally saw some action today.
UVCL Acting Skiddish uptick to .0016x.0017
From reading up on the DD on CSCE, wouldnt want to be in the sidelines when filings hit. Here are a few links to read up on looks like a winner regardless, even if MMG is holding this shell.
Address match on NVSOS
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62836382
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=htTYgUXfModuOX2AbOZRDw%253d%253d&CorpName=CASCADE+ENERGY%2c+INC.
205 Million A/S
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=htTYgUXfModuOX2AbOZRDw%253d%253d&nt7=0
DD Compilation
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59326583
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59690999
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62826967
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59179851
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62210944
thnx been watchin..startin to heat up on the otc merger front again it seems..will see..bring us some %%%% all i know.
anyone talk to anyone there with the company/ceo?TIA
radared
Recent correspondence with CSCE IR, which SOMEONE mysteriously erased from CSCE iBox proved dispositively that NO CSCE reverse merger is in the works. Truth... it is what it is no matter what get's erased.
CSCE - Reinstatement - (09FEB2011) after 4years of inactivity! 205 Million shares Authorized, SOMETHING IS BREWING BEHIND THE SCENES!
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=htTYgUXfModuOX2AbOZRDw%253d%253d&CorpName=CASCADE+ENERGY%2c+INC.
Shell CIST .002 looks like a reverse merger:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62578918
USFM is an operating company with a new CEO, Jim Farooquee , and peeps are speculating R/M possibilities...
Jim Farooquee - Mr. Farooquee with association of CBR Commercial, a Real Estate broker, brings several decade of experience in investing, developing and sales of residential and commercial Real Estate. Mr. Farooquee has been an entrepreneur for 30 years; building his high tech firm with a $12,000 investment in 1987 to over $400,000,000 in 1994 as the CEO he sold his position of New York Stock exchange listed company. He brings vast knowledge of mergers and acquisitions and strategic partnership with like minded investors and financial partners. His extensive background in Green Energy technologies and Real Estate project development gives him the ability to bring together right people, talents and products-technologies into practical projects.
Having years of experience running a public company Mr. Farooquee negotiated multi million dollar deals and brought several rounds of investments dollars worth over one hundred million dollars to the company. An expert in mergers, acquisitions, financing and investment strategies Mr. Farooquee feels right at home to provide assistance, support and reinforcement to this project.
http://ih.advfn.com/p.php?pid=nmona&article=46868209
Anymore information or specifics on this? tia.
watch PNHV 10 for 1 reverse split. In the sec fillings
NFBH getting close read the last filing.
Yeah... doesn't look like they have a lot of debt on the balance sheet too. The problem is volume... these suckers are completely dead and rarely see any action. Have to watch them... possibly for a long time too...
STQN getting some volume new high today....
Gregory, so what do you think? They look pretty clean. Low o./s too.
LJPC.PK 0.04 potential R/M OR OTHER DEAL BEFORE FEB24, must read, according to 13g just filed, TANG cap. owns 9.3% or 8.840M shares. LJPC is well financed, feb 25 is the deadline for deal.
Remember key facts:
1) LJPC signed potential 16,3m financing (common stock, preferred convertible stock, some issued, other to be issued if transaction achieved). 1st tranche of financing was about 6 mln $, next due if Transaction reached within 24 february 2011 (even also Preferred shareholders may waive to this condition...)
2) LJPC appointed B. C. LIANG to BOD (ex AMGEN, BIOGEN, NIH) who serves as director in numerous companies such as Tracon & Pico Pharmas, and is ceo of Pfenex bio. Liang is a great scientist and should rebuild co. pipeline. Riquent, potential lupus drug, may be partnered again, and a new, better designed ph3 (change of patients subset, endpoints), may start. Biomarin was the last partner for Riquent (ASPEN study), found futile in ph3. Co doesn't agree that Riquent is futile, because showed statistically significance efficacy limited to certain endpoints and was safe and well tolerated.
3) Co. retained new indipendent registred CPA, dismissing E&J.
4) Co. failed to merge with ADAMIS, last year, because didn't met the quorum and positive votes in shareholders meetings.
5) If Riquent partnered and approved, LJPC may become a billionaire bio co. Watch HGSI and compare!
company received 1st round of financing on may 24 2010, with the committment to find a merger or rm or license for its lupus drug RIQUENT before 9 months in order to get new financing (worth 16mln $ overall). In last weeks co. appointed new officer and confirms CPA, that would mean deal is in the works.
this is a binary event because co. should liquidate if unable to find partner or deal, but the recent event suggested me that something is in the works.
10bagger lupus stock LJPC .03 all timelow R/M player 95 mill OS liquidation value at least .02 more than 7 millions cash per share or 7 cents per share excluding RIQUENT for LUPUS a ph3 drug safe which effectiveness may be shown with a new clinical trial
announcement expected at any moment, nothing of sure, but this co. was historically a FENIX!!!
------------------------------------------------------------------------------------
La Jolla Pharmaceutical Company Announces Appointment of Dr. Bertrand C. Liang to Board of Directors
Press Release Source: La Jolla Pharmaceutical Company On Tuesday December 7, 2010, 9:00 am
SAN DIEGO--(BUSINESS WIRE)-- La Jolla Pharmaceutical Company (OTCBB:LJPC.ob - News) (the “Company”) today announced that Dr. Bertrand C. Liang has been appointed to the Company’s Board of Directors. Dr. Liang is Chief Executive Officer of Pfenex Inc., a biotech company focused on the production of innovator proteins, reagent proteins, and biosimilars, and Capital Member of Forward Ventures/Medical Science Partners. He has worked in the development and financing of biopharmaceuticals for the last 20 years, including at Amgen, Biogen Idec, the National Institutes of Health, Paramount Biosciences and Tracon Pharmaceuticals. Dr. Liang serves on the Board of Directors of Tracon Pharmaceuticals and Pico Pharmaceuticals, Ltd.
Dr. Liang attended Northwestern Medical School and the University of Bolton, with business school at the Regis School of Professional Studies and the Sloan School of Management, emphasizing Strategy and Innovation. Dr. Liang’s clinical training was completed at Brown University and the University of Michigan, with post-doctoral studies at the National Center for Human Genome Sciences and the National Cancer Institute.
“Dr. Liang’s breadth of medical expertise, extensive experience in technology evaluation and small company building and his proven development skills will all be of tremendous value to La Jolla as we seek to establish a pipeline and rebuild the Company”, said Deirdre Y. Gillespie, M.D., President and Chief Executive Officer of La Jolla Pharmaceutical Company. “We are very excited indeed that he is joining our Board of Directors”.
About La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to improving and preserving human life by acquiring and developing innovative pharmaceutical products. In May 2010, the Company completed a private placement of its securities for up to $16.3 million in gross proceeds, payable in two tranches and subject to the acquisition of a suitable drug candidate or the approval of a development plan for Riquent®. The Company expects to use a portion of the initial $6.0 million in proceeds to evaluate potential pharmaceutical products for in-licensing or acquisition and/or to assess whether development opportunities for Riquent exist, among other uses. The Company has historically focused on the development and testing of Riquent as a treatment for lupus nephritis. The Phase 3 clinical trial for Riquent, called the “ASPEN” study, was terminated in February 2009, after the Independent Data Monitoring Board for the ASPEN study informed the Company that they had completed the first interim efficacy analysis and determined that continuing the study was futile. Although continuing the ASPEN study was determined to be futile with respect to the clinical endpoints, Riquent did demonstrate a statistically significant, dose dependent reduction in antibodies to double-stranded DNA when compared to placebo and appeared to be well tolerated. No clinical development activities are currently ongoing while the Company evaluates future candidates for development.
------------------------------------------------------------------------------------
La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire
LJPC.PK 0.02180 0.00
Release Source: La Jolla Pharmaceutical Company On Tuesday September 7, 2010, 9:00 am EDT
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (OTCBB:LJPC - News) (the “Company”) provided an update today that the Company is actively seeking and evaluating potential pharmaceutical products for in-licensing or acquisition and has engaged consultants to determine whether there is any potential for the further development of Riquent® for the treatment of lupus. The Company is seeking potential pharmaceutical products that are small molecules with initial clinical data indicated for cancer, infectious diseases (but not HIV, HCV or HBV), dermatological conditions, gastrointestinal diseases and rare or orphan diseases. This profile is designed to target product opportunities that could be advanced in a clinically meaningful way with the cash resources currently available to the Company. Gail Sloan is the contact for this effort at gail.sloan@ljpc.com.
The Company expects to complete its process of identifying potential candidates by September 30, 2010, and thereafter focus its attention on selecting a potential candidate for development.
In May 2010, the Company entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, redeemable convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds, payable in two tranches and subject to the acquisition of a suitable drug candidate or the approval of a development plan for Riquent. The Company expects to use a portion of the initial $6.0 million in proceeds to evaluate potential pharmaceutical products for in-licensing or acquisition and/or to assess whether development opportunities for Riquent exist, among other uses. A condition of this funding is that the Company must consummate a strategic transaction that is approved by a majority of the investors in the private placement by February 2011. Upon the acquisition/in-licensing of a product or the decision to develop, sell or out-license the Company’s Riquent program, the same investors are required to infuse the additional $10.3 million into the Company, which would represent the closing of the second tranche of the offering.
About La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to improving and preserving human life by acquiring and developing innovative pharmaceutical products. The Company has historically focused on the development and testing of Riquent as a treatment for lupus nephritis. The Phase 3 clinical trial for Riquent, called the “ASPEN” study, was terminated in February 2009, after the Independent Data Monitoring Board for the ASPEN study informed the Company that they had completed the first interim efficacy analysis and determined that continuing the study was futile. Although continuing the ASPEN study was determined to be futile with respect to the clinical endpoints, Riquent did demonstrate a statistically significant, dose dependent reduction in antibodies to double-stranded DNA when compared to placebo and appeared to be well tolerated. No clinical development activities are ongoing, and the Company is assessing whether there is any potential for further development of Riquent.
yup it jus needs to do somethin and merge outta nowhere!)love thin shells all i know!))
CSLX namechange outta nowhere on the daily list today!
first move in over a decade last known OS 2.34m and moves like it!!traded in dollars back in the day too! hopefully megaRMer there and hopefully a FS which would be icing imo!
Yep if those other stocks GWAY and CSLX can run. Imagine ENCP!
ENCP i still have some of that one put away!
EN_CP .04x.06 low OS shell under 700k OS and active on CO SOS. Got some filngs done already for otcbb. Just need a few more and will be otc.
NFBH all in one DD: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59132814
SERIOUS HCKI might swell soon. Heavy hitters all over it.
AEOH.........did a REVERSE merger with an oil company owned by a former Pres of XON in Arabia
He isnt here for penny deals
I see the stock way over $2 and heading for teh AMEX
IZZI.ob .0080 volumes and pps up shell with 0.01$ + net cash no debt, bv and nols worth up to 0.05, after asset sale now a no debt shell.
A single shareholder following debt conversion in to equity owns 79% of OS, insiders globally owns 82% of OS, float will be further reduced after reverse split 1/100 in order to increase shareholder value and get financing upon Reverse Merger done.
News will be out end of month, best regards
Dear Followers,
Hot Penny Picks is an active helpful informational board that is posting on older dried up boards that have one to zero posts a day to help grow its following and help diversify its posters. Our goal is to become one of the top boards with hundreds of posts a day (which it has now) and a good place to share DD and bounce ideas off of one another. Were a growing board gaining followers every day and have on average 150-200 posts a day. We have made several picks all having great returns and the more people following the harder we work, the Hotter the picks get.
The link to the board is in my tag ;)
There is some buzz about AEGP. I was hoping you could analyze it and offer up an assessment. There's some DD on that board that lends itself to imagination, with the possibility/rumor being that there will be a reverse merger with Global Foundries, a company worth billions. Thank you.
ATYG (.05) reverse MERGER!!!! woo hooo!!!
Good insights here HDOGTX. Glad to find a place where people are talking mergers. I am pretty new here but would welcome the chance to compare notes with you guys.
WMDL - this was a Stocker shell. Now on the move BIG
MGHL : shell with cash / assets Total assets $ 365,977
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=7383860
PFOB...
This shell has an offer and is in the hands of the court system. VERY small float.
These reverse mergers have various stages of readiness and upside potential. Here's a list I made maybe it can help people going forward.
Good one, everyone what else should go on this list. People putting too much money into those stage 1's and 2's without understanding how these things work. There would be a lot more cash on the sidelines inclined to invest in these mergers if they all didn't get trapped in dead shells that might never do a deal. So what else needs to be added to this list?
Rainmaker Merger Countdown Chart
Stage 1 would be a dormant shell who is suddenly reactivated (Weakest one, could be a year+ before they do anything). Also, a shell who suddenly raises their A/S or creates some new Preferred shares would be a stage 1. Still weak.
Stage 2: would be filing a 15-12g (Still very weak, might be nothing more than someone who couldn't afford their auditor anymore, unless coupled with a name change).
Stage 3: would be a change in officers and company address (This one is a decent place to real radar this one, maybe nibble a bit). What you want to see is the new officers have a decent track record on past business deals especially if they did a successful merger in the past.
Stage 4: would be a name change (I split this stage into two lists. One's I can not find any info on new company. These I watch but don't buy. A real company who is already doing a lot of business should be al over google. The good one's are the one's where new company name is all over google, appears to have decent revenue.
Now even if you make it through these four stages, Stage 5 is the make it or break it stage.
Stage 5: How do they structure the merger. What percent of new company do shell holders end up with. 20-30% of new company is a dream split. 10% workable, less not usually a good deal. Also, do they do a R/S a deal killer almost every time.
Bottom line until you make it to stage 5, get the answers you need regarding share structure after the merger, confirm no R/S and get a feel whether new management is shareholder friendly....these are lotto's you throw a few dollars at hoping to get lucky. After Stage 5 you can find some life changing deals after filtering down to a few strong one's who are about to be up and running.
By: The Rainmaker Share Wednesday, September 29, 2010 11:17:05 AM
Re: nsomniyak post# 25832 Post # of 25840
Sounds Great Red!!
I think I may put in an order for a few mil tomorrow.
03
E(GL)A could be a good sleeper, or not. it has a website and is active in the save our souls database. it is .0004x.001
.....................................
from otcmarkets.com website:
Eagle Telephonics, Inc.
3880 Veterans Memorial Hwy.
Suite 203
Bohemia, NY 11716
http://www.eagletelephonics.com
* Phone: 631-471-3600
* Fax: 631-471-6595
* E-mail: eagle@eagle-tel.com
-------------------------------------
http://appext9.dos.state.ny.us/corp_public/CORPSEARCH.ENTITY_INFORMATION?p_nameid=780751&p_corpid=694614&p_entity_name=eagle%20telephonics&p_name_type=A&p_search_type=BEGINS&p_srch_results_page=0
Current Entity Name: EAGLE TELEPHONICS, INC.
Initial DOS Filing Date: APRIL 22, 1981
County: SUFFOLK
Jurisdiction: NEW YORK
Entity Type: DOMESTIC BUSINESS CORPORATION
Current Entity Status: ACTIVE
......................................
disclaimer: no eagles were harmed during the filming of this post.
SLPT, Now is a developmewnt stage company, New Owners, now in Tokyo Japan, Float 6,444,592.
Yes NXPN looks very good!!
Thx for this! NXPN interesting one!
GPGD Grand Pacaraima Gold Corporation Has Signed the "Agreement and Plan of Merger/Acquisition" and Completed Its Merger/Acquisition
Today : Wednesday 15 September 2010
Grand Pacaraima Gold Corporation (PINKSHEETS: GPGD) announced today that the board of directors finalized the merger with Jasmine EKA Karya, Inc., a US Corporation, with the signing of the "Agreement and Plan of Merger/Acquisition."
David Nolan, CEO of Jasmine, believes this merger will greatly enhance the Company's ability to complete a number of domestic and international contracts now under negotiations, relating mainly to the petrochemical industry.
GPGD Board of Directors commented, "This transaction should be a positive move for GPGD's existing shareholders. Our commitment is to provide increased equity and shareholder value on a continuing basis through the continued acquisition of new assets, mergers, acquisitions, expansion and development of our existing holdings."
About Jasmine EKA Karya Inc.
Jasmine EKA Karya Inc., a US Corporation is headed up by David Nolan, as its Chief Executive Officer (CEO). Jasmine was formed as a commodity trading company dealing in the petroleum industry. Their main emphasis as a General Contractor is petrochemical infrastructure in construction of drilling rig, refineries, ports and energy related projects.
About Grand Pacaraima Gold Corp. (GPGD) -- www.GPGD.PK
The Company's principal business has been the acquisition of mining and mineral properties. Management's new emphasis is on energy projects, mergers and acquisitions related to the energy industry.
Forward-Looking Statements: Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
NXPN name change will be hitting the daily list soon to High Plains Gas, Inc. ...
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=gMJzGfHyV8O0pLGzqELduA%253d%253d&nt7=0
Followers
|
238
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2825
|
Created
|
05/14/07
|
Type
|
Free
|
Moderator HDOGTX | |||
Assistants odiaz28 WIDESPREAD PANIC |
This board is designed to List and Update the High Profile Shell Merger/Facilitator's and thier current reinstatement or reverse meger deals. The lists we make will also include the business consulting firms hired to assist witht these mergers. Filings by well-established shell players (Anthony, Smith, Stocker, Meuse, Weintrich, Gottlieb, etc) are typically indicators that they plan to move it for profit near-term.....prepare it for sale to a privately-held company that wants to go public in the cheapest way possible.
This board is intended to give players visibility to these types of potential plays. Mark the board! Its a good one to have immediate access to.........
Shell Stock List 250 + active shell stocks Updated - June 07
Added over 40 active shells since the May update. Created a tab focused exclusively on key shell players. Added in CIK#'s for ease in tracing EDGAR filings. pps's illustrated are as of May 31 closing prices.
Useful TA links for company searches:
http://www.stocktransfer.com/index.cfm?action=professionals.TALookup.default
http://tadirectory.com/TASearch.htm
Cagan & McAfee
Joseph Bartel
David Price
Wayne Mower
Mark Smith Nevada:
406-667-2332
Mark Smith is a known RevMerger facilitator. He recently helped Regions Oil RM with FCNK. FCNK then went on a run from .008 to 3.70 per share. The first signs of life of FCNK before the merger were the REINSTATEMENT of the company with Nevada's SOS, an SEC filing of form 15-12g, and a change in Agents.....just like what has been done with FBCE and many other companies in the past few months.
AECH, CBFE, DMGB, FBCE, GVHL, IDGN, INAN, KSGI, LNBO, LMGR, MNEI, MRXT, OTLK, PLSO, PSNN, PSPM, RLYC, STUS, RYAE, TINN, TSFY, TINV, RXMS, TMXU, SYME, UTDE, WUFG, YZBG, ZLNK,
Michael Anthony Nevada:
ATGDQ, CINN, MWEB, SNQS, STII, STCC, TVCE, UBDT
David B. Stocker
Mr. David Stocker of Phoenix, AZ is an attorney that specilizes in seeking out dormant, aged, and seemingly uncared for public entities that once operated with viable ongoing business operations.
He is a professional and is well known in his field, one part of his business is the sale of public shell companies. He and his staff look for companies that have not kept their filings up within their respective states of incorporation , and appear to have abandoned their duties as directors of said companies. Many do not realize that it is possible to gain custody of these old corporations if one can prove in court that they have been "abandoned".
Stocker files a civil suit in the target company's State and seeks to be appointed custodian of the corporation in the action. Many of these old companies have been out of operation for years, and nobody is paying attention or is aware of his (Stockers) action(s). He is only legally required to print notice in local legal journals (journals that are georapically located within a reasonable distance of the defendant's last known place of business) that he and his firm is seeking custodianship. Not many people read these legal journals unless they are in the profession. But, it is considered service by publication on the defendant in the action.
http://www.stockerlaw.com
AIHC, AOME, AQRO, BLFE, CTKI, MNET, VERD, SEQL, POPM, IMAI, FONM, WMDL
All of David Stocker's filings
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2779602
http://www.secinfo.com/$/SEC/Name.asp?X=david+b%2E+stocker
Is David B. Stocker as good as Michael Anthony or Mark Smith with completing reverse mergers with these shells?
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2779602
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=1956309
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=1980869
Joseph Meuse
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2260310
AZTC, DPWI,GKSY
Kevin Keating, Michael J. Keating, Timothy J. Keating
Pay close attention to the Keating shells. I know Smith, Stocker and Anthony get most of the attention, but the ROI's on Keatings' plays are usually exceptionally high. They are already in the teens or higher when KI picks them up, taking ownership of 85% or more of the play. Then they move them to clean private plays that typically run north of $1 when merger announced.....
http://www.keatinginvestments.com/team.html
Contact margie blackwell of keating investments
Keating shells have a history of often going to dollars.....and they are absolutely CLEAN when he moves them
Kevin Keating http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2013510
Timothy J Keating http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2655784
Michael J. Keating
IPOR, FRZR, QBYT, CCVR, IFSG, PUDC, AGWI, ARGA,, BPMA, BLUE, DFXN, HYDG, PPLB, SORL
FRZR .14 x .16 82MM sOut
QBYT .30 x .75 79MM sOut
IPOR .12 x .14 98MM sOut
Eugene Koppenhaver list of shells STCE, DBTX, RDWG, VMTF, IQMC,
& CWOV
Master List of Brian Goldenberg Controlled Shells
SASN-MEIX-YIWA-MHTD-GVEC-PNCR-MELL-WRCI
PTXX-REDM-FUNN-NURS-VTCHQ-IRBB-JSIBQ-SBUFQ
It appears Mark Rentschler (who was responsible for the UMCC reverse merger that went from under .01 up to .20 per share) has teamed up with Brian Goldenberg to start doing reverse mergers with these 15 shells. Here is the proof. MEIX merger documents page 6 says Mark Rentschler was just the CEO of MEIX before it was transferred to Robert Clark.
http://www.sunbiz.org/COR/2007/0627/04482668.Tif
Howard B. Weintrich
http://freeadvice.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=1954293
Jay A. Gottlieb
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2032862
CDSI, SPAZ
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2032862
Wesley F. Whiting
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2211771
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=3612054
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2905525
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=2211771
Resources
Shell Stock Watch: http://www.shellstockwatch.com
Shellstockreview: http://www.shellstockreview.com/ssr-Home.html
Shell Stocks: http://www.shellstocks.com/
Platinum Penny Stocks: http://www.platinumpennystocks.com
Corporate standings of companies all 50 states: http://www.coordinatedlegal.com/SecretaryOfState.html
SEC Info Search: http://www.secinfo.com/$/Search.asp
Explanation of filings:
http://www.gsionline.com/support/formtypes.html
Pinksheet filings: http://www.pinksheets.com
OTCBB filings: http://www.otcbb.com
OTCBB Daily List for Symbol changes: http://www.otcbb.com/asp/dailylist_detail.asp?d=05/11/2007&mkt_ctg=NON-OTCBB
How to find shells recently reactivated: http://investorshub.advfn.com/boards/board.asp?board_id=10763
Reverse Mergers: http://www.investorshub.com/boards/board.asp?board_id=7308
How to find Reverse Merger candidates before they're announced - http://www.investorshub.com/boards/read_msg.asp?message_id=19588389
Reverse Merger Association: http://www.reversemergerassociation.com/
SHELL STOCKS FOR SALE
MergerNetwork.com: http://www.mergernetwork.com/c/public-shell-companies-for-sale/
Search Web page properties:
http://www.networksolutions.com/whois/index.jsp
Consulting firms specializing in Reverse Mergers:
Absolute IPO.com: http://www.absoluteipo.com/
Adar Group: http://www.adargroup.com/
Airam Capital Group, Inc.: http://www.airamcapital.com/
Alliance Acquisitions: http://www.aallcusa.com/
Belmont Capital Group: http://www.bcghk.com/eng/home.html
Coral Capital Partners: http://www.coralcapital.com/
Deal Flow Media: http://www.dealflowmedia.com/
Flex Financial Group, Inc.: http://www.flexfinancialgroup.com/
Global Mergers Group: http://www.mergergroupllc.com/
Go Public.com: http://www.gopublic.com/
Halter Capital Corp: http://www.halter.com/
Innovation Public Shells: http://www.innovationcapital.biz/
IPO Capital Underwritings: http://www.ipo-capital.com/
IPO Alternative: http://www.ipoalternative.com/
Keating Investments: http://www.keatinginvestments.com/
Mergers-R-Us.com:
Merger Station
OTCBBShell.Com
OTC Traders
Public Spinoff
Reverse Merger.com
Reverse Mergers.Net
Timber Creek Corp
Venture Associates
Warner Technology and Investment Corp.
DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information
Posts Today
|
0
|
Posts (Total)
|
2825
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |